secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0001493152-23-007281
Event type: regulatory
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa files Section 205 petition to validate charter amendment after Boxed decision uncertainty
--------------------------------------------------------------------------------

- Filed petition in Delaware Chancery on March 9, 2023 seeking validation of Second Amended and Restated Certificate of Incorporation and all shares issued.
- Uncertainty arose from Boxed decision questioning whether separate class vote was required for reduction of authorized shares from 220M to 110M.
- Court granted expedited proceedings; final hearing set for March 29, 2023 at 11:00 a.m. ET.
- Company had 9,211,922 shares outstanding as of petition date; all shares remain below authorized limits.
- If validation not granted, could affect ability to raise capital and Nasdaq listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223007281/0001493152-23-007281-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223007281/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-007281

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer